https://youtu.be/YAdrzoSuvww

Animal testing is absolutely necessary for advancing biotech, I've concluded. When the right time, right circumstance, and right money come, I will do laboratory animal testing for advancing medical biotech, human longevity biotech, human genetic engineering biotech, human body manufacturing and replacement biotech, human fertility duration lengthening biotech, and other types of biotechnologies. I've a multidecadal commitment to advancing biotech for enabling long-lasting human life and youth, longer human fertility duration, and better human health for everyone.

Doing laboratory animal testing in the U.S. requires adhering to the U.S. federal, state, and local regulations. Boston in Massachusettes, and San Franciso in California, in particular, perform the most numbers of animal tests in the U.S., for advancing biomedicine and biotech.

The Animal Welfare Act is the U.S. federal law that regulates testing on certain types of animals.

According to my calculation, maintaining an Animal Welfare Act compliant animal testing facility in the U.S. requires at least a multiple six-figure U.S. dollars annual overhead or biotech research expense, and most likely over one-million U.S. dollars annual biotech research overhead; as such, it is not cheap.

Because my aim is building a variety of biotech businesses at Robocentric, with multiple biotech product lines, I don't have to have an Animal Welfare Act compliant animal testing facility in the U.S. to launch the first Robocentric biotech products. As such, I'll first establish and operate an animal testing facility in the U.S. that isn't applicable to the Animal Welfare Act, a non-Animal Welfare Act applicable animal testing facility in the U.S., which will be much cheaper than operating an Animal Welfare Act compliant animal testing facility in the U.S., and have very low overhead.

Robocentric will get into a variety of biotech businesses—namely research and medical biotech devices development and manufacturing, medicinal biotech, cosmetic biotech, supplement biotech, and industrial and consumer biomatter design and manufacturing biotech.

For a lot of the biotech products that Robocentric will develop and market, an Animal Welfare Act compliant animal testing facility won't be absolutely required, and a non-Animal Welfare Act applicable animal testing facility will do, although eventually Robocentric will need one or more Animal Welfare Act compliant animal testing facilities—perhaps in Boston, San Francisco, or both and maybe in other locations—for pushing biotech development and commercialization to the uttermost extremes.

Robocentric will do nonhuman animals genetic engineering experiments, documentation, and publication for advancing medical biotech for curing human genetic diseases by replacing disease-causing human genes with healthy human genes.

Robocentric will do fully robotized genetically engineered nonhuman animal care in confinement for the experiments, 3D scanning, and results publication.

Robocentric will write and publish "Robocentric biotech development plan for nonhuman animals genetic engineering experiments, documentation, and publication for advancing medical biotech for curing human genetic diseases by replacing disease-causing human genes with healthy genes".

Robocentric will do genetic engineering experiments especially on nonhuman primates, for creating improved nonhuman primates with faster reproduction cycles, and for creating human genetic disease cures.

Robocentric will write and publish "Robocentric biotech development protocols and processes for breeding and performing experiments on nonhuman primates for developing medical biotech with regulations to abide by".

Robocentric will do age acceleration and deceleration, anti-aging, and deaging biotech development experiments on nonhuman primates such as on chimps for medical research including cancer cure research,